The success of SBT-100 in suppressing uveitis or encephalomyelitis in mice provides a template for use of SBT-100 Nanobody in modulating undruggable transcription factors such as STAT1 and STAT3 (35, 78). This evidence concerns the gene STAT3 and uveitis.